Greg Barrett, VP Marketing and Managed Markets at Daiichi Sankyo
The partnership between Daiichi Sankyo and Partners HealthCare's Center for Connected Health to bring mobile device monitoring to atrial fibrillation patients is still in its early stages, so there's no data to share from the pilot. But Partners VP of Connected Care Dr. Joseph Kvedar and Greg Barrett, VP of Marketing and Managed...
Apple hasn't changed any of the health sensors or features of its soon-to-launch Apple Watch device since it first announced it last fall. That may be common knowledge to most, but there seems to be a growing number of people who believe Apple scrapped its health features in February. Well, it didn't.
A few weeks ago The Wall Street Journal published a must-read exclusive that reported Apple had...
Going "beyond the pill" doesn't just mean devising new digital technologies to market a drug or promote medication adherence with software tools. Sometimes it means engaging patients in their patient journey long before a drug enters into the equation -- and hoping it pays dividends later on.
Jeremy Shepler, senior director of diabetes marketing at Novo Nordisk, spoke at the ePharma Summit last...
The ePharma Summit in New York City this week was a veritable smorgasbord of new mobile health data. Monique Levy shared some new data (and insights) from Manhattan Research, Tom Jones from Makovsky Health shared data about consumer mobile health use, and, finally, ComScore's John Mangano shared data from a survey of 2,929 individuals, broken down by generation.
"So what I did was I had my team...
Paul Ivans
As payors and providers advance toward outcomes-based medicine, that shift is affecting pharmaceutical companies as well. As decisions about prescribing shift away from the doctor, who has been the primary recipient of pharma marketing for the past 20 years, to the C-level of integrated delivery networks (IDNs) and accountable care organizations (ACOs), pharma is going to have to...
Monique Levy, VP of Research at Manhattan Research
Although there's a lot of buzz about wearables and a lot of talk about tablets, the best digital channel to reach patients and consumers is still the smartphone, according to Manhattan Research's Monique Levy. At the ePharma Summit in New York City, Levy shared some data with an assembled crowd of pharma marketers about how patients use mobile...
